Behandlung des nichtkleinzelligen Lungenkarzinoms
- 19 November 2011
- journal article
- Published by Springer Nature in Die Innere Medizin
- Vol. 52 (12) , 1414-1421
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung CancerNew England Journal of Medicine, 2010
- Consensus for EGFR Mutation Testing in Non-small Cell Lung Cancer: Results from a European WorkshopJournal of Thoracic Oncology, 2010
- Current data on predictive markers for anti-angiogenic therapy in thoracic tumoursEuropean Respiratory Journal, 2010
- Randomized Phase III Trial of Vinorelbine Plus Cisplatin Compared With Observation in Completely Resected Stage IB and II Non–Small-Cell Lung Cancer: Updated Survival Analysis of JBR-10Journal of Clinical Oncology, 2010
- Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study GroupsJournal of Clinical Oncology, 2008
- Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative GroupJournal of Clinical Oncology, 2008
- Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancerNature, 2007
- DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant ChemotherapyNew England Journal of Medicine, 2006
- Molecular determinants of response to RTK‐targeting agents in nonsmall cell lung cancerInternational Journal of Cancer, 2006
- Bronchoscopy‐guided transtracheal and transbronchial fine‐needle aspiration biopsy: A 5‐year institutional review of 111 casesDiagnostic Cytopathology, 2002